LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout
If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) on the same day, you are…
Direxion Daily S&P Biotech Bull 3X Shares, managed by Rafferty Asset Management, is an exchange-traded fund that aims to offer three times the daily performance of the S&P Biotechnology Select Industry Index. Focusing on the U.S. equity markets, it invests in biotech and life sciences companies through stocks, derivatives, and other funds. This fund targets both growth and value stocks across various market capitalizations, making it a dynamic choice for those interested in the biotech sector.
If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) on the same day, you are…
Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and renewed merger activity pulled capital back into a sector that spent much of the…
Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull 3X Shares (NASDAQ:LABU) offers the most aggressive way to capture that move.…